Identification of glossodynia-associated saliva microRNA with the use of next generation sequencing
Project/Area Number |
24659897
|
Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
Allocation Type | Single-year Grants |
Research Field |
Surgical dentistry
|
Research Institution | Ehime University |
Principal Investigator |
NAKASHIRO Koichi 愛媛大学, 医学(系)研究科(研究院), 准教授 (90314880)
|
Project Period (FY) |
2012-04-01 – 2014-03-31
|
Project Status |
Completed (Fiscal Year 2013)
|
Budget Amount *help |
¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2013: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2012: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Keywords | 舌痛症 / 唾液 / microRNA / 次世代シーケンサー |
Research Abstract |
In this study, we attemptedIn this study, we attempted to identify a specific microRNA (miRNA) in saliva derived from patients with glossodynia. By next generation sequencing, no specific miRNA was detected in saliva from glossodynia patients. In microarray analysis, we found 6 increased miRNAs in saliva from glossodynia patients. These miRNAs may be useful for diagnosis of glossodynia.
|
Report
(3 results)
Research Products
(21 results)
-
[Journal Article] Immuno- chemoradiotherapy for patients with oral squamous cell carcinoma : augmentation of OK-432-induced helper T cell 1 response by 5-FU and X-ray irradiation2013
Author(s)
Tano T, Okamoto M, Kan S, Bando T, Goda H, Nakashiro K, Shimodaira S, Koido S, Homma S, Fujita T, Sato M, Yamashita N, Hamakawa H, Kawakami Y
-
Journal Title
Neoplasia
Volume: 15(7)
Pages: 805-14
Related Report
Peer Reviewed
-
-
[Journal Article] Prognostic impact of expression of bcl-2 and bax genes in circulating immune cells derived from patients with head and neck carcinoma2013
Author(s)
Tano T, Okamoto M, Kan S, Nakashiro K, Shimodaira S, Koido S, Homma S, Sato M,Fujita T, Kawakami Y, Hamakawa H
-
Journal Title
Neoplasia
Volume: 15(3)
Pages: 305-14
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-